|
Q3 FY2026
As of Jun 27, 2026
|
Q2 FY2026
As of Mar 28, 2026
|
Q1 FY2026
As of Dec 27, 2025
|
Q4 FY2025
As of Sep 27, 2025
|
Q3 FY2025
As of Jun 28, 2025
|
Q2 FY2025
As of Mar 29, 2025
|
Q1 FY2025
As of Dec 28, 2024
|
Q4 FY2024
As of Sep 28, 2024
|
Q3 FY2024
As of Jun 29, 2024
|
Q2 FY2024
As of Mar 30, 2024
|
Q1 FY2024
As of Dec 30, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 24, 2023
|
Q2 FY2023
As of Mar 25, 2023
|
Q1 FY2023
As of Dec 24, 2022
|
Q4 FY2022
As of Sep 24, 2022
|
Q3 FY2022
As of Jun 25, 2022
|
Q2 FY2022
As of Mar 26, 2022
|
Q1 FY2022
As of Dec 25, 2021
|
Q4 FY2021
As of Sep 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, less allowance for doubtful accounts of $6,807 and $5,107 respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND PARTNERS’ CAPITAL | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued employment and benefit costs | ||||||||||||||||||||
| Accrued insurance | ||||||||||||||||||||
| Customer deposits and advances | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||||
| Accrued insurance | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Partners’ capital: | ||||||||||||||||||||
| Common Unitholders (66,712 and 65,485 units issued and outstanding at June 27, 2026 and September 27, 2025, respectively) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total partners’ capital | ||||||||||||||||||||
| Total liabilities and partners’ capital | ||||||||||||||||||||
Loading...
